国家: 澳大利亚
语言: 英文
来源: Department of Health (Therapeutic Goods Administration)
budesonide, Quantity: 0.64 g/L
Arrotex Pharmaceuticals Pty Ltd
Budesonide
Spray, suspension
Excipient Ingredients: purified water; hydrochloric acid; glucose monohydrate; potassium sorbate; disodium edetate; polysorbate 80; microcrystalline cellulose; carmellose sodium
Nasal
120 doses
(S2) Pharmacy Medicine
For short term (3-6 months) prophylaxis or treatment of seasonal allergic rhinitis in adults and children,aged 12 years and over and perennial allergic rhinitis in adults 18 years and over.
Visual Identification: White suspension; Container Type: Aerosol - Pump Actuated Metered Dose; Container Material: Glass Type III Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-05-18